Skip to main content
. 2022 Jan 18;2(1):62–70. doi: 10.1016/j.jacasi.2021.10.009

Table 1.

Patient Characteristics

All (N = 656) ALDH2 Wild (n = 430) ALDH2∗1/∗2 (n = 199) ALDH2∗2/∗2 (n = 27) P Value
Age, y 64 (55-71) 63 (53-71) 65 (58-71) 68 (57-72) 0.42
Male 403 (61.4) 273 (63.5) 112 (56.3) 18 (66.7) 0.20
BMI, kg/m2 23.2 (20.9-25.6) 23.2 (21.1-25.7) 23.2 (20.8-25.4) 23.1 (21.8-26.2) 0.65
BNP, pg/mL 28.3 (12.9-66.4) 28.5 (13.6-65.9) 28.0 (12.6-69.1) 17.3 (10.4-50.3) 0.60
EF, % 63.3 (60.0-66.2) 63.5 (60.0-66.7) 62.9 (59.8-65.6) 64.5 (61.1-67.4) 0.13
LADs, mm 35.9 ± 6.3 36.3 ± 6.3 35.2 ± 6.3 34.3 ± 6.5 0.03
eGFR, mL/min/1.73 m2 72.0 (62.0-85.0) 72.0 (63.0-85.0) 70.0 (60.0-84.0) 65.0 (56.5-81.0) 0.09
Atrial fibrillation 392 (59.8) 261 (60.7) 122 (61.3) 9 (33.3) 0.02
Hypertension 343 (52.2) 236 (54.9) 96 (48.2) 11 (40.7) 0.14
Diabetes mellitus 92 (14.0) 54 (12.3) 35 (17.6) 3 (11.1) 0.23
Drinking habit 282 (43.0) 231 (53.7) 51 (25.6) 0 (0) <0.001
Current smoking 129 (19.7) 88 (20.4) 36 (18.0) 5 (18.5) 0.78

Values are median (interquartile range), n (%), or mean ± SD.

ALDH2 = aldehyde dehydrogenase; BMI = body mass index; BNP = brain natriuretic peptide; EF = ejection fraction; eGFR = estimated glomerular filtration rate; LAD = left atrial dimension.